Journals / Retina-Vitreus / 2004 / Cilt: 12 - Sayı: 1

The effictivity of posterior subtenon triamcinolone acetonide injection in patients with diabetic macular edema

Diabetik makula ödem tedavisinde posterior subtenon triamsinolon asetonid enjeksiyonunun etkinliği

Pages
42–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We think that posterior subtenon triamcinolone acetonide injection after grid laser photocoagulation is an effective method which decrease diabetic macular edema and increase visual acuity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:After the treatment of diabetic macular edema with modified grid laser therapy we try to evaluate the visual prognose changes with and without triamcinolone acetonid therapy.
📊
Key Findings & Data:This study included 40 eyes of 35 patients with diabetic macular edema.
💡
Conclusion & Impact:We think that posterior subtenon triamcinolone acetonide injection after grid laser photocoagulation is an effective method which decrease diabetic macular edema and increase visual acuity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Retina hastalıkları · Görme keskinliği · Triamsinolon asetonit

Abstract

After the treatment of diabetic macular edema with modified grid laser therapy we try to evaluate the visual prognose changes with and without triamcinolone acetonid therapy. This study included 40 eyes of 35 patients with diabetic macular edema. Modified grid laser photocoagulation were applied to the 20 eyes (group 1) and 1 ml posterior subtenon triamcinolone acetonide were applied after modified grid laser photocoagulation treatment to the other 20 eyes (group 2) In group 1; snellen visual acuity decreased in 3 of 20 eyes (15%) and visual acuity remained stable or increased one snellen line in 14 of 20 eyes (70%). In 3 of 20 eyes (15%) 2 or more snellen lines improvement was observed. In group 2; there was no visual loss. In 12 of 20 eyes (60%) vision was the same or one snellen line increased. Snellen visual acuity improved by 2 or more lines in 8 of 20 (40%) eyes. The difference between the two groups was statistically significant (p<0,01). We think that posterior subtenon triamcinolone acetonide injection after grid laser photocoagulation is an effective method which decrease diabetic macular edema and increase visual acuity.

Özet

Diabetik makula ödemi tedavisinde modifiye grid lazer tedavisi sonrası subtenon triamsinolon asetonid uygulanan ve uygulanmayan olgularda görme prognozunun değerlendirilmesi Çalışmaya diabetik makula ödemi olan 35 hastanın 40 gözü dahil edildi. Yirmi göze yalnız modifiye grid lazer tedavisi uygulandı (grup 1), diğer 20 göze modifiye grid lazer tedavisi sonrası 1 ml posterior subtenon triamsinolon asetonid enjeksiyonu yapıldı (grup 2). Grup 1'de 20 gözün 3'ünde (%15) görme kaybı oldu. 14 gözde (%70) görme aynı kaldı veya snellen eşelinde bir sıra arttı. 3 gözde (%15) görme iki sıra veya daha çok arttı. Grup 2'de görme kaybı olmadı. 20 gözün 12'sinde (%60) görme aynı kaldı veya bir sıra arttı. 8 gözde (%40) görme iki sıra veya daha fazla arttı. İki grup arasında yapılan karşılaştırmada fark istatistiksel olarak anlamlı bulundu (p<0,01). Makula ödemi tedavisinde grid lazer fotokoagülasyonu sonrası posterior subtenon triamsinolon asetonid enjeksiyonunun makula ödemini azaltmada ve görme keskinliğini artırmada etkili olduğunu düşünmekteyiz.

🔖

Cite This Article

UÇGUN, N. İ., YAZAR, Z., BİLGİN, B., SEMİZ, F., GÜRSEL, E. (2004). The effictivity of posterior subtenon triamcinolone acetonide injection in patients with diabetic macular edema. Retina-Vitreus, Cilt: 12 - Sayı: 1, 42–44. https://ajindex.com/articles/305370

References (14)

  1. Folk, J.C., Pullido, J.S.: Diabetic macular edema, Ophthalmology Monographs 11: Laser photocoagulation of the retina and choroid MO, 1997: 25-61
  2. Jonas JB, Kreissing I, Sofker A, et al: A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age related macular dejeneration: one year results. Arch OphthalmoJ 2003; 121:57-61
  3. Martidis A, Duker JS, Greenberg PB, et al: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109:920-927
  4. Penfold PL, Wong JG, Gyory J, et al: Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-III Clin. Experiment Ophthalmol 2001; 29: 188-192
  5. Wallow IH. Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol 1984; 102:126-135
  6. Shartz H, Madeina D, McDonald R, et al: Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 1991,-1549-1551
  7. Freeman WR, Green RL, Smith RE.: Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol 1987;! 5; 103: 281-288
  8. Roth DB, Chieh J, Spirn MJ, et al: Noninfections endophtalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003; 121: 1279-1282
  9. Oik RJ, Öz Ö.: Diabetik makula ödeminde laser fotokoagülasyon; diabetik makula ödemi ve katarakt diabetik makula ödemi ve proliferatif diabetik retinopati. Ret-Vit 2002; 10: 214-218
  10. Wilson CA, Berkowitz BA, Sato Y, et al: Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation Arch Ophthalmol 1992; 110:1155-1159
  11. Levin DS, Han DP, Deu S, et al: Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation Am J Ophthalmol 2002; 133: 196-202
  12. Helm CJ, Holland GN: The effects of posterior subtenon injection of triancinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995; 120: 55-64
  13. Karaçorlu M, Özdemir H, Alacalı N, ve ark.: Diffüz diabetik makula ödemi tedavisinde intravitreal triamsinolon. T Oft Gaz 2003; 33: 488-497
  14. Park CH, Joffe GJ, Fekrat S: Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 136:419-425.